We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $453M
1-Year Est. Return 20.63%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+20.63%
3 Year Est. Return
+53.69%
5 Year Est. Return
+69.59%
10 Year Est. Return
+264.58%
AUM
$185M
AUM Growth
+$1.29M
Cap. Flow
-$2M
Cap. Flow %
-1.08%
Top 10 Hldgs %
22.96%
Holding
97
New
1
Increased
24
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$192K
2
MOS icon
The Mosaic Company
MOS
+$114K
3
CHRW icon
C.H. Robinson
CHRW
+$91.7K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$83.4K
5
VZ icon
Verizon
VZ
+$79.2K

Top Sells

Rank Stock Value
1
HWM icon
Howmet Aerospace
HWM
+$1.88M
2
HPE icon
Hewlett Packard
HPE
+$210K
3
DE icon
Deere & Co
DE
+$175K
4
AAPL icon
Apple
AAPL
+$146K
5
CMCSA icon
Comcast
CMCSA
+$115K

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.41%
2 Industrials 16.29%
3 Technology 12.65%
4 Financials 12.53%
5 Healthcare 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.71T
$5.47M 2.96%
79,342
-1,210
-2% -$83.1K
MMM icon
2
3M
MMM
$86.9B
$4.47M 2.42%
25,661
-120
-0.5% -$20.1K
CSCO icon
3
Cisco
CSCO
$431B
$4.4M 2.38%
140,516
-10
-0% -$326
AAPL icon
4
Apple
AAPL
$4.67T
$4.25M 2.3%
118,128
-3,960
-3% -$146K
MA icon
5
Mastercard
MA
$507B
$4.09M 2.21%
33,662
-460
-1% -$54.6K
MCD icon
6
McDonald's
MCD
$181B
$4.08M 2.21%
26,617
-415
-2% -$60K
PEP icon
7
PepsiCo
PEP
$188B
$4M 2.17%
34,681
-520
-1% -$59.7K
IWM icon
8
iShares Russell 2000 ETF
IWM
$81.2B
$3.94M 2.13%
27,928
-280
-1% -$38.8K
INTC icon
9
Intel
INTC
$506B
$3.91M 2.12%
115,993
-770
-0.7% -$27.6K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.08T
$3.84M 2.08%
22,687
-165
-0.7% -$27.4K
ABBV icon
11
AbbVie
ABBV
$453B
$3.83M 2.07%
52,879
-70
-0.1% -$4.71K
KO icon
12
Coca-Cola
KO
$379B
$3.74M 2.02%
83,427
-400
-0.5% -$17.7K
IEMG icon
13
iShares Core MSCI Emerging Markets ETF
IEMG
$165B
$3.72M 2.01%
74,378
+498
+0.7% +$24.6K
XOM icon
14
ExxonMobil
XOM
$656B
$3.69M 2%
45,687
+554
+1% +$45.3K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$110B
$3.67M 1.99%
52,395
+1,204
+2% +$83.4K
WMT icon
16
Walmart Inc
WMT
$850B
$3.63M 1.96%
143,796
-480
-0.3% -$12.2K
LH icon
17
Labcorp
LH
$26.5B
$3.58M 1.94%
27,058
+163
+0.6% +$20K
ACN icon
18
Accenture
ACN
$114B
$3.48M 1.89%
28,181
+40
+0.1% +$4.87K
GE icon
19
GE Aerospace
GE
$350B
$3.48M 1.88%
26,903
+457
+2% +$62.6K
XYL icon
20
Xylem
XYL
$24.7B
$3.48M 1.88%
62,802
-180
-0.3% -$9.37K
CL icon
21
Colgate-Palmolive
CL
$70.8B
$3.48M 1.88%
46,890
-30
-0.1% -$2.23K
DE icon
22
Deere & Co
DE
$187B
$3.43M 1.85%
27,737
-1,490
-5% -$175K
RTX icon
23
RTX Corp
RTX
$271B
$3.42M 1.85%
44,498
-715
-2% -$53.6K
MDT icon
24
Medtronic
MDT
$120B
$3.32M 1.79%
37,385
+35
+0.1% +$2.95K
CMCSA icon
25
Comcast
CMCSA
$94B
$3.27M 1.77%
83,906
-2,930
-3% -$115K

Similar funds

Boston Research & Management's Q2 2017 Portfolio in Review

As of Q2 2017, Boston Research & Management held 97 positions worth $185M, up 0.7% from $184M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.1%. Boston Research & Management opened 1 new position and exited 2, leaving the 97-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

  • Boston Research & Management's largest Q2 2017 buy was Amgen: 1,180 shares worth $203K.
  • Boston Research & Management added most to The Mosaic Company in Q2 2017, an estimated $114K increase.
  • Boston Research & Management's biggest Q2 2017 reduction was Deere & Co, cutting an estimated $175K.
  • Boston Research & Management fully exited Howmet Aerospace in Q2 2017, selling an estimated $1.88M.
  • Boston Research & Management's ten largest holdings make up 23% of its $185M portfolio in Q2 2017.
  • Boston Research & Management opened 1 new position and closed 2 in Q2 2017.
  • Boston Research & Management's portfolio value rose 0.7% quarter-over-quarter to $185M.

Based on Boston Research & Management's 13F filing for Q2 2017, filed 8 Aug 2017.